首页|The dopaminergic system and Alzheimer's disease
The dopaminergic system and Alzheimer's disease
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
万方数据
Alzheimer's disease is a common neurodegenerative disorder in older adults.Despite its prevalence,its pathogenesis remains unclear.In addition to the most widely accepted causes,which include excessive amyloid-beta aggregation,tau hyperphosphorylation,and deficiency of the neurotransmitter acetylcholine,numerous studies have shown that the dopaminergic system is also closely associated with the occurrence and development of this condition.Dopamine is a crucial catecholaminergic neurotransmitter in the human body.Dopamine-associated treatments,such as drugs that target dopamine receptor D and dopamine analogs,can improve cognitive function and alleviate psychiatric symptoms as well as ameliorate other clinical manifestations.However,therapeutics targeting the dopaminergic system are associated with various adverse reactions,such as addiction and exacerbation of cognitive impairment.This review summarizes the role of the dopaminergic system in the pathology of Alzheimer's disease,focusing on currently available dopamine-based therapies for this disorder and the common side effects associated with dopamine-related drugs.The aim of this review is to provide insights into the potential connections between the dopaminergic system and Alzheimer's disease,thus helping to clarify the mechanisms underlying the condition and exploring more effective therapeutic options.
adverse drug reactionAlzheimer's diseasecatecholaminedopamine receptordopamine receptor heterodimersdopaminergic systemneurodegenerative diseaseneurotransmittersignaling pathwaystraditional Chinese medicinetreatment
Yuhan Zhang、Yuan Liang、Yixue Gu
展开 >
International Medical College,Chongqing Medical University,Chongqing,China
College of Pharmacy,Chongqing Medical University,Chongqing,China
Department of Neurology,The First Affiliated Hospital of Chongqing Medical University,Chongqing Key Laboratory of Neurology,Chongqing,China